Pure Global

First-into-human Study of NS-136 in Healthy Subjects - Trial NCT06345703

Access comprehensive clinical trial information for NCT06345703 through Pure Global AI's free database. This Phase 1 trial is sponsored by NeuShen Therapeutics and is currently Recruiting. The study focuses on Healthy Subjects. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06345703
Phase 1
Recruiting
drug
Trial Details
ClinicalTrials.gov • NCT06345703
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
First-into-human Study of NS-136 in Healthy Subjects
A Phase 1, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and PK of Single and Multiple Ascending Oral Doses and Food Effect of NS-136 in Healthy Subjects

Study Focus

Healthy Subjects

Placebo

Interventional

drug

Sponsor & Location

NeuShen Therapeutics

Adelaide, Australia

Timeline & Enrollment

Phase 1

Apr 30, 2024

Feb 01, 2025

60 participants

Primary Outcome

Number of Participants with Treatment-Related Adverse Events,Main pharmacokinetic parameters,Main pharmacokinetic parameters,Main pharmacokinetic parameters,Main pharmacokinetic parameters,Main pharmacokinetic parameters,Main pharmacokinetic parameters

Summary

The goal of this clinical trial is to exlplore the profile of NS-136 in health conditions.
 The main questions it aims to answer are:
 
 - Is NS-136 safe and tolerable in heathy subjects under tested dosing regimen?
 
 - What is the pharmacokinectic profile of NS-136 in healthy subjects under tested dosing
 regimen?

ICD-10 Classifications

Occupational health examination
Seeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmful
Routine child health examination
Examination and observation for other reasons

Data Source

ClinicalTrials.gov

NCT06345703

Non-Device Trial